Deep learning-based risk stratification for HER2-negative breast cancer patients
M. I. Jaber, L. Beziaeva, C. W. Szeto, S. C. Benz
The paper uses deep learning to analyze digital pathology images and clinicopathological data to improve risk stratification for HER2-negative breast cancer patients.
bioRxiv · May 26, 2021 · PreprintPathology